Wells Fargo
YARW

Wells Fargo’s Yarrow Bioscience YARW Stock Holding History

Wells Fargo’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42 Hold
1
– – ﹤0.01% 6762
2026
Q1 		$39 Hold
1
– – ﹤0.01% 6645
2025
Q4 		$38 Hold
1
– – ﹤0.01% 6585
2025
Q3 		$22 Hold
1
– – ﹤0.01% 6682
2025
Q2 		$107 Hold
1
– – ﹤0.01% 6473
2025
Q1 		$103 Hold
1
– – ﹤0.01% 6373
2024
Q4 		$218 Hold
1
– – ﹤0.01% 6355
2024
Q3 		$122 Hold
1
– – ﹤0.01% 6262
2024
Q2 		$128 Sell
1
-2
-67% -$249 ﹤0.01% 6230
2024
Q1 		$535 Hold
3
– – ﹤0.01% 6265
2023
Q4 		$400 Buy
3
+1
+50% +$156 ﹤0.01% 6434
2023
Q3 		$424 Hold
2
– – ﹤0.01% 6398
2023
Q2 		$365 Hold
2
– – ﹤0.01% 6550
2023
Q1 		$268 Hold
2
– – ﹤0.01% 6697
2022
Q4 		$235 Sell
2
-1
-33% -$200 ﹤0.01% 6575
2022
Q3 		$0 Buy
3
+1
+50% +$320 ﹤0.01% 7460
2022
Q2 		$0 Hold
2
– – ﹤0.01% 7585
2022
Q1 		$1K Hold
2
– – ﹤0.01% 6877
2021
Q4 		$1K Buy
+2
New +$2.15K ﹤0.01% 7089
2021
Q2 		– Sell
-9
Closed -$53K – 7509
2021
Q1 		$53K Sell
9
-26
-74% -$189K ﹤0.01% 5793
2020
Q4 		$200K Buy
35
+5
+17% +$31.4K ﹤0.01% 5089
2020
Q3 		$181K Sell
30
-2
-6% -$11.7K ﹤0.01% 5008
2020
Q2 		$200K Buy
32
+17
+113% +$115K ﹤0.01% 4914
2020
Q1 		$143K Buy
15
+6
+67% +$94.1K ﹤0.01% 4880
2019
Q4 		$152K Hold
9
– – ﹤0.01% 5111
2019
Q3 		$152K Buy
9
+1
+13% +$16.1K ﹤0.01% 5119
2019
Q2 		$180K Buy
8
+1
+14% +$24.7K ﹤0.01% 5031
2019
Q1 		$184K Buy
7
+3
+75% +$72K ﹤0.01% 4867
2018
Q4 		$64K Buy
+4
New +$89.5K ﹤0.01% 5449
2018
Q3 		– Hold
0
– – – 5900
2018
Q2 		– Hold
0
– – – 6066
2018
Q1 		– Hold
0
– – – 5642

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wells Fargo's YARW Position: Q2 2026 in Review

Wells Fargo held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 1 share worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #6762.

Wells Fargo first reported a position in YARW in Q4 2018 and has held it in 29 quarters since. The position peaked at $200K in Q4 2020. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Wells Fargo held 1 share of Yarrow Bioscience worth $42 as of Q2 2026.
  • Wells Fargo left its Yarrow Bioscience share count unchanged in Q2 2026.
  • Yarrow Bioscience made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6762 holding.
  • Wells Fargo first reported a position in Yarrow Bioscience in Q4 2018 and has held it in 29 quarters since.
  • Wells Fargo's Yarrow Bioscience position peaked at $200K in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.